BHC 6.03 ▼ -1.31% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bausch Health Companies I...

    NYSE: BHC · Real-Time Price · USD
    6.03
    -0.08 (-1.31%)
    At close: Oct 15, 2025, 3:59 PM
    6.02
    -0.08%
    After-hours: Oct 15, 2025, 04:16 PM EDT
    -1.31%
    Bid 6
    Market Cap 2.23B
    Revenue (ttm) 9.83B
    Net Income (ttm) 98M
    EPS (ttm) 0.26
    PE Ratio (ttm) 23.17
    Forward PE 1.49
    Analyst Hold
    Dividends n/a
    Ask 6.09
    Volume 976,049
    Avg. Volume (20D) 2,571,368
    Open 6.19
    Previous Close 6.11
    Day's Range 5.97 - 6.19
    52-Week Range 4.25 - 9.85
    Beta 0.43
    Ex-Dividend Date n/a

    About BHC

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol BHC
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for BHC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Bausch Health Companies Inc. is scheduled to release its earnings on Oct 29, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 months ago
    +4.74%
    Bausch Health shares are trading higher after the ... Unlock content with Pro Subscription
    2 months ago
    -7.82%
    Bausch Health shares are trading lower after the company reported mixed Q2 adjusted EPS results.
    news image

    6 days ago · accessnewswire.com

    Bausch Health Announces Results of Special Meeting of Shareholders

    LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2...

    news image

    2 weeks ago · accessnewswire.com

    Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV

    The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage® FLX, Clear + Brilliant®, and Fraxel FTX™ offer energy-based treatment options that help maintain a youthful appea...

    news image

    2 weeks ago · accessnewswire.com

    Bausch Health to Announce Third Quarter 2025 Results on October 29

    LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025....

    news image

    2 weeks ago · accessnewswire.com

    Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

    Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue. Nine-episode inaugural season hosted by industry thought leader Melissa K.

    news image

    1 month ago · seekingalpha.com

    Bausch Health: Repricing Continues As Deleveraging Gains Traction

    Bausch Health remains a Buy as the market overstates debt and patent risks, while the business shows stable cash generation and operational momentum. Q2 results confirmed growth in core segments, impr...

    news image

    1 month ago · accessnewswire.com

    Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

    The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline LAV...

    news image

    1 month ago · businesswire.com

    Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

    VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Ameri...

    news image

    1 month ago · accessnewswire.com

    Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System

    LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aest...

    news image

    1 month ago · zacks.com

    Bausch (BHC) Up 21.4% Since Last Earnings Report: Can It Continue?

    Bausch (BHC) reported earnings 30 days ago. What's next for the stock?

    news image

    1 month ago · accessnewswire.com

    Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

    LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) t...

    Add to Watchlist